Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Lebers congenital Amaurosis, Syndromic retinal degenerations, age-related macular degeneration and Usher Syndrome, and hearing loss associated with Usher Syndrome are described herein.